Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Mounjaro, NHS
Weight-loss drug Mounjaro will help 'so many' people, say users
Weight-loss drug Mounjaro is set to be rolled out on the NHS in England from March. It is one of many weight-loss drugs that have become increasingly popular in recent years, and are sold privately by clinics and pharmacies.
How new NHS weight loss jab Mounjaro works and eligibility amid 12-year waiting list
As the NHS prepares to roll out Mounjaro for patients struggling with obesity, many eligible patients will be facing a lengthy wait to get hold of the drug. So who actually qualifies?
Obese people ‘will have to wait’ for weight loss jab Mounjaro, NHS officials warn
However, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, warned that weight loss jabs “are not a magic bullet”.
NHS gets 12 years to roll out new weight-loss drug Mounjaro
A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the NHS drugs advisory body says. The National Institute for Health and Care Excellence (NICE) final draft guidance on Mounjaro has recommended it starts being given from March, alongside advice on diet and exercise.
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than Wegovy, a drug with the main active ingredient semaglutide, according to new data released Wednesday by Eli Lilly, the maker of Zepbound.
Lilly to Boost Weight-Loss Drug Supply With $3 Billion Expansion
Eli Lilly & Co. is spending another $3 billion to build out its US manufacturing footprint as it ramps up production of its blockbuster diabetes and weight-loss drugs.
Why the New Weight Loss Drugs Don't Work for Some People
Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% of their body weight. But the drugs don’t work for everyone. In tho
What is new weight loss jab Mounjaro and is it available on the NHS?
“Mounjaro is the brand name for tirzepatide, a weekly injectable weight-loss medication which has recently been approved for use in the UK and is now available to order with a prescription online,” says Dr Mitra Dutt, GP from LloydsPharmacy Online Doctor.
The ‘King Kong of weight-loss drugs’ – what is Mounjaro and who will be eligible for it?
The ‘King Kong of weight-loss drugs’ – what is Mounjaro and who will be eligible for it? - Fewer than 10% of patients in England who are eligible will initially be able to access it on the NHS.
1d
Zepbound leads to more weight loss than Wegovy, new study finds
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
19h
Zepbound Leads to More Weight Loss Than Wegovy in Head-to-Head Clinical Trial
Drug manufacturer Eli Lilly says their drug Zepbound is more effective than Wegovy for long-term weight loss. Results from a ...
1d
Comedian Jim Gaffigan’s Weight Loss Transformation Over the Years After Shedding 50 Pounds
Actor and comedian Jim Gaffigan made sure his 50-pound weight loss was funny business, discussing the topic in his November ...
Business Insider
18h
U.K. to limit Eli Lilly’s Mounjaro to patients with greatest need, STAT reports
The U.K. will start offering Eli Lilly’s (LLY)
weight
loss
drug
Mounjaro
next year, but will restrict the medicine to people with the greatest need as the country tries to adapt to new ways of ...
2d
on MSN
Exclusive-Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular ...
4h
on MSN
Lilly planning $3B expansion of Wisconsin plant to boost production
Eli Lilly (NYSE:LLY) plans to boost production of its popular diabetes and weight-loss medications with a $3B expansion of ...
5h
on MSN
Eli Lilly announces $3 billion expansion at manufacturing site in Wisconsin
Eli Lilly and Company has announced a $3 billion expansion to a manufacturing facility in Wisconsin that is set to bring over ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Eli Lilly and Company
Zepbound
Wegovy
Ozempic
NHS
Feedback